Chapter 188 Glomerular Disease and Nephrotic Syndrome

  1. Atkins CE et al: The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog, J Vet Pharmacol Ther 30:394, 2007. PUBMED Abstract
  2. Bakris GL: Slowing nephropathy progression: focus on proteinuria reduction, Clin J Am Soc Nephrol 3:S3, 2008. PUBMED Abstract
  3. Cattran D: Management of membranous nephropathy: when and why for treatment, J Am Soc Nephrol 16:1188, 2005. PUBMED Abstract
  4. Cook AK, Cowgill LD: Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992), J Am Anim Hosp Assoc 32:313, 1996. PUBMED Abstract
  5. Grauer GF et al: Effects of enalapril vs placebo as a treatment for canine idiopathic glomerulonephritis, J Vet Intern Med 14:526, 2000. PUBMED Abstract
  6. Klosterman ES et al: Association between nephrotic syndrome and signalment, clinicopathologic abnormalities, histologic diagnosis, and prognosis in dogs with glomerular disease, J Vet Intern Med 25:206, 2011.
  7. Linas SL: Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease, Clin J Am Soc Nephrol 3:S17, 2008. PUBMED Abstract
  8. McAlister FA et al: The safety of combining angiotensin-converting enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis, Can Med Assoc J 183:E309, 2011. PUBMED Abstract
  9. Schjoedt KJ et al: Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial, Diabetologia 52:46, 2009. PUBMED Abstract
  10. Segev G et al: Renal amyloidosis in dogs: a retrospective study of 91 cases with comparison of the disease between Shar-pei and non Shar-pei dogs, J Vet Intern Med 26:259, 2012. Epub January 23, 2012. PUBMED Abstract